• Login
Read without ads. Subscribe KOMPAS.com+
Indonesia Approves Sinovac Covid-19 Vaccine for Emergency Use in Children Aged 6 to 11
The authorization was based on the evaluation of phase 2 clinical trials that the immunogenicity of the Sinovac vaccine reached 96.5 percent.
Back to article...
Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More headlines

Read without ads. Subscribe KOMPAS.com+
COMMENTS
MOST POPULAR
Read without ads. Subscribe KOMPAS.com+
Read without ads. Subscribe KOMPAS.com+
Close Ads

Copyright 2008 - 2026 PT. Kompas Cyber Media (Kompas Gramedia Digital Group). All Rights Reserved.